Skip to Content

尊敬的客户:

目前国际形势复杂多变,关税政策尚不明朗,这可能对我们的产品价格产生一定影响。在此情况下,我们希望就订单事宜与您进行友好沟通。

基于当前的不确定性,如果您选择在此期间下单,我们将保留根据实际情况调整价格的权利。同时,我们也理解市场变化可能给您带来的困扰,因此如果在订单实际发货前因关税政策变动导致价格出现较大波动,默克将与您进行协商讨论并视情况对订单进行调整或取消。

We are planning system maintenance between Friday, Apr 18 at 9:00 PM CDT and Saturday, Apr 19 at 9:00 AM CDT. This will impact both web and offline transactions, including online orders, quotes, price and availability checks, and order status inquiries. We apologize for any inconvenience.

关于应对近期政策变化的重要更新,请点击此处查看详情。

Merck
CN
  • Antibody Epitope of Human α-Galactosidase A Revealed by Affinity Mass Spectrometry: A Basis for Reversing Immunoreactivity in Enzyme Replacement Therapy of Fabry Disease.

Antibody Epitope of Human α-Galactosidase A Revealed by Affinity Mass Spectrometry: A Basis for Reversing Immunoreactivity in Enzyme Replacement Therapy of Fabry Disease.

ChemMedChem (2018-02-24)
Zdenek Kukacka, Marius Iurascu, Loredana Lupu, Hendrik Rusche, Mary Murphy, Lorenzo Altamore, Fabio Borri, Stefan Maeser, Anna Maria Papini, Julia Hennermann, Michael Przybylski
ABSTRACT

α-Galactosidase (αGal) is a lysosomal enzyme that hydrolyses the terminal α-galactosyl moiety from glycosphingolipids. Mutations in the encoding genes for αGal lead to defective or misfolded enzyme, which results in substrate accumulation and subsequent organ dysfunction. The metabolic disease caused by a deficiency of human α-galactosidase A is known as Fabry disease or Fabry-Anderson disease, and it belongs to a larger group known as lysosomal storage diseases. An effective treatment for Fabry disease has been developed by enzyme replacement therapy (ERT), which involves infusions of purified recombinant enzyme in order to increase enzyme levels and decrease the amounts of accumulated substrate. However, immunoreactivity and IgG antibody formation are major, therapy-limiting, and eventually life-threatening complications of ERT. The present study focused on the epitope determination of human α-galactosidase A against its antibody formed. Here we report the identification of the epitope of human αGal(309-332) recognized by a human monoclonal anti-αGal antibody, using a combination of proteolytic excision of the immobilized immune complex and surface plasmon resonance biosensing mass spectrometry. The epitope peptide, αGal(309-332), was synthesized by solid-phase peptide synthesis. Determination of its affinity by surface plasmon resonance analysis revealed a high binding affinity for the antibody (KD =39×10-9  m), which is nearly identical to that of the full-length enzyme (KD =16×10-9  m). The proteolytic excision affinity mass spectrometry method is shown here to be an efficient tool for epitope identification of an immunogenic lysosomal enzyme. Because the full-length αGal and the antibody epitope showed similar binding affinities, this provides a basis for reversing immunogenicity upon ERT by: 1) treatment of patients with the epitope peptide to neutralize antibodies, or 2) removal of antibodies by apheresis, and thus significantly improving the response to ERT.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Fmoc-His(Trt)-OH, ≥98.0% (sum of enantiomers, HPLC)
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Tyr(tBu)-OH, ≥98.0% (HPLC)
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Ser(tBu)-OH, ≥98.0% (HPLC)
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Thr(tBu)-OH, ≥98.0% (HPLC)
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Phe-OH, 98%
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Ala-OH, 95%
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Trp(Boc)-OH, ≥97.0% (HPLC)
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Gln(Trt)-OH, ≥98.0% (HPLC)
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Pro-OH, ≥90% (HPLC)
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Met-OH, ≥98.0% (HPLC)
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Ile-OH, ≥98.0% (T)
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Val-OH, ≥98.0% (HPLC)
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58
Sigma-Aldrich
Fmoc-Leu-OH, ≥97.0%
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
10 ea
Estimated to ship on July 17, 2025
Details...
CN¥11,276.58